Go Pro

Ardent Health (ARDT) Competitors

Ardent Health logo
$10.06 +0.26 (+2.65%)
As of 01:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ARDT vs. BLLN, CELC, RDNT, SHC, and CAI

Should you buy Ardent Health stock or one of its competitors? MarketBeat compares Ardent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ardent Health include Billiontoone (BLLN), Celcuity (CELC), RadNet (RDNT), Sotera Health (SHC), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Ardent Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M19.35$7.45M$0.55233.40
Ardent Health$6.32B0.23$135.81M$0.9510.73

Ardent Health has a net margin of 2.09% compared to Billiontoone's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
Ardent Health 2.09%13.85%4.48%

Billiontoone presently has a consensus target price of $126.00, suggesting a potential downside of 1.85%. Ardent Health has a consensus target price of $14.04, suggesting a potential upside of 37.81%. Given Ardent Health's higher probable upside, analysts plainly believe Ardent Health is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36

In the previous week, Billiontoone had 4 more articles in the media than Ardent Health. MarketBeat recorded 12 mentions for Billiontoone and 8 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.40 beat Billiontoone's score of 0.37 indicating that Ardent Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ardent Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Ardent Health beats Billiontoone on 9 of the 13 factors compared between the two stocks.

How does Ardent Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Celcuity has a beta of 0.16, indicating that its stock price is 84% less volatile than the broader market. Comparatively, Ardent Health has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Celcuity presently has a consensus price target of $155.18, indicating a potential upside of 81.18%. Ardent Health has a consensus price target of $14.04, indicating a potential upside of 37.81%. Given Celcuity's stronger consensus rating and higher probable upside, research analysts plainly believe Celcuity is more favorable than Ardent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36

Ardent Health has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$177.04M-$3.90N/A
Ardent Health$6.32B0.23$135.81M$0.9510.73

Ardent Health has a net margin of 2.09% compared to Celcuity's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -244.61% -50.22%
Ardent Health 2.09%13.85%4.48%

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 1.9% of Ardent Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Celcuity had 10 more articles in the media than Ardent Health. MarketBeat recorded 18 mentions for Celcuity and 8 mentions for Ardent Health. Celcuity's average media sentiment score of 0.82 beat Ardent Health's score of 0.40 indicating that Celcuity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
7 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive
Ardent Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Ardent Health beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Ardent Health compare to RadNet?

Ardent Health (NYSE:ARDT) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardent Health2.09% 13.85% 4.48%
RadNet -0.66%2.77%0.97%

77.9% of RadNet shares are held by institutional investors. 1.9% of Ardent Health shares are held by company insiders. Comparatively, 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardent Health$6.32B0.23$135.81M$0.9510.73
RadNet$2.14B2.34-$18.65M-$0.18N/A

In the previous week, Ardent Health had 4 more articles in the media than RadNet. MarketBeat recorded 8 mentions for Ardent Health and 4 mentions for RadNet. RadNet's average media sentiment score of 0.56 beat Ardent Health's score of 0.40 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardent Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
RadNet
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ardent Health presently has a consensus price target of $14.04, indicating a potential upside of 37.81%. RadNet has a consensus price target of $87.43, indicating a potential upside of 36.91%. Given Ardent Health's higher probable upside, equities research analysts clearly believe Ardent Health is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80

Ardent Health has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, RadNet has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market.

Summary

Ardent Health beats RadNet on 10 of the 17 factors compared between the two stocks.

How does Ardent Health compare to Sotera Health?

Ardent Health (NYSE:ARDT) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends and analyst recommendations.

Ardent Health currently has a consensus price target of $14.04, indicating a potential upside of 37.81%. Sotera Health has a consensus price target of $20.25, indicating a potential upside of 10.95%. Given Ardent Health's higher probable upside, equities analysts clearly believe Ardent Health is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

91.0% of Sotera Health shares are owned by institutional investors. 1.9% of Ardent Health shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sotera Health has a net margin of 9.91% compared to Ardent Health's net margin of 2.09%. Sotera Health's return on equity of 39.73% beat Ardent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardent Health2.09% 13.85% 4.48%
Sotera Health 9.91%39.73%7.05%

In the previous week, Ardent Health had 5 more articles in the media than Sotera Health. MarketBeat recorded 8 mentions for Ardent Health and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.45 beat Ardent Health's score of 0.40 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardent Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardent Health$6.32B0.23$135.81M$0.9510.73
Sotera Health$1.19B4.38$77.94M$0.4144.51

Ardent Health has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.76, suggesting that its stock price is 76% more volatile than the broader market.

Summary

Sotera Health beats Ardent Health on 11 of the 16 factors compared between the two stocks.

How does Ardent Health compare to Caris Life Sciences?

Ardent Health (NYSE:ARDT) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Ardent Health currently has a consensus price target of $14.04, indicating a potential upside of 37.81%. Caris Life Sciences has a consensus price target of $26.11, indicating a potential upside of 52.62%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than Ardent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36
Caris Life Sciences
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45

In the previous week, Caris Life Sciences had 3 more articles in the media than Ardent Health. MarketBeat recorded 11 mentions for Caris Life Sciences and 8 mentions for Ardent Health. Caris Life Sciences' average media sentiment score of 0.89 beat Ardent Health's score of 0.40 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardent Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Caris Life Sciences
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ardent Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardent Health$6.32B0.23$135.81M$0.9510.73
Caris Life Sciences$812.03M5.96-$68.09M-$7.61N/A

Caris Life Sciences has a net margin of 3.75% compared to Ardent Health's net margin of 2.09%. Caris Life Sciences' return on equity of 98.28% beat Ardent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardent Health2.09% 13.85% 4.48%
Caris Life Sciences 3.75%98.28%48.87%

Summary

Caris Life Sciences beats Ardent Health on 8 of the 13 factors compared between the two stocks.

Get Ardent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARDT vs. The Competition

MetricArdent HealthMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.46B$9.50B$6.87B$23.45B
Dividend YieldN/A1.62%2.68%4.02%
P/E Ratio10.7325.4127.2131.18
Price / Sales0.2326.32516.66164.10
Price / Cash3.56113.3748.6332.25
Price / Book0.866.1910.814.79
Net Income$135.81M$177.20M$3.59B$1.07B
7 Day Performance1.21%0.15%-2.12%0.97%
1 Month Performance9.61%8.71%3.24%1.05%
1 Year Performance-15.16%14.37%26.02%18.47%

Ardent Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARDT
Ardent Health
4.2532 of 5 stars
$10.06
+2.7%
$14.04
+39.6%
-30.0%$1.44B$6.32B10.5925,200
BLLN
Billiontoone
1.8322 of 5 stars
$120.70
-2.2%
$126.00
+4.4%
N/A$5.56B$305.11M219.74620
CELC
Celcuity
3.3231 of 5 stars
$113.79
+4.8%
$152.09
+33.7%
+564.1%$5.55BN/AN/A40
RDNT
RadNet
3.3794 of 5 stars
$67.84
-1.6%
$87.43
+28.9%
+10.7%$5.33B$2.04BN/A11,264
SHC
Sotera Health
3.3897 of 5 stars
$17.84
-0.1%
$20.25
+13.5%
+59.5%$5.08B$1.16B43.483,000

Related Companies and Tools


This page (NYSE:ARDT) was last updated on 7/16/2026 by MarketBeat.com Staff.
From Our Partners